CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
Sychev, DA, Baturina, OA, Mirzaev, KB, Rytkin, E, Ivashchenko, DV, Andreev, DA, Ryzhikova, KA, Grishina, EA, Bochkov, PO, Shevchenko, RVVolume:
Volume 13
Journal:
Pharmacogenomics and Personalized Medicine
DOI:
10.2147/PGPM.S234910
Date:
January, 2020
Fichier:
PDF, 656 KB
2020
File converter
Plus de résultats de recherche
More benefits 
